FWIA
NVO

Fort Washington Investment Advisors’s Novo Nordisk NVO Stock Holding History

Fort Washington Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,911
Closed -$202K – 406
2025
Q1 		$202K Sell
2,911
-100
-3% -$8.26K ﹤0.01% 392
2024
Q4 		$259K Hold
3,011
– – ﹤0.01% 375
2024
Q3 		$359K Hold
3,011
– – ﹤0.01% 352
2024
Q2 		$430K Buy
3,011
+51
+2% +$6.76K ﹤0.01% 337
2024
Q1 		$380K Hold
2,960
– – ﹤0.01% 345
2023
Q4 		$306K Buy
2,960
+100
+3% +$9.89K ﹤0.01% 349
2023
Q3 		$260K Hold
2,860
– – ﹤0.01% 350
2023
Q2 		$231K Hold
2,860
– – ﹤0.01% 364
2023
Q1 		$228K Buy
+2,860
New +$203K ﹤0.01% 369

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fort Washington Investment Advisors's NVO Position: Q2 2025 in Review

Fort Washington Investment Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,911 shares — an estimated $202K sold.

Fort Washington Investment Advisors first reported a position in NVO in Q1 2023 and held it in 9 quarters. The position peaked at $430K in Q2 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Fort Washington Investment Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 2,911 Novo Nordisk shares in Q2 2025, an estimated $202K.
  • Fort Washington Investment Advisors first reported a position in Novo Nordisk in Q1 2023 and held it in 9 quarters.
  • Fort Washington Investment Advisors's Novo Nordisk position peaked at $430K in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2025, filed 17 Jul 2025.